Morgan Stanley China A Share Fund, Inc.
NYSE:CAF
12.8 (USD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| -78.531 | -10.906 | -2.445 | -29.094 | -25.621 | -16.28 | 42.175 | 47.456 | 15.808 | 8.35 | 28.603 |
| Cost of Revenue
| 2.217 | 2.449 | 3.218 | 3.27 | 3.702 | 4.487 | 4.753 | 4.925 | 4.283 | 4.496 | 4.431 |
| Gross Profit
| -80.748 | -13.355 | -5.663 | -32.364 | -29.323 | -20.767 | 37.422 | 42.531 | 11.525 | 3.854 | 24.172 |
| Gross Profit Ratio
| 1.028 | 1.225 | 2.316 | 1.112 | 1.144 | 1.276 | 0.887 | 0.896 | 0.729 | 0.462 | 0.845 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 73.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 40.569 |
| Operating Expenses
| 73.82 | 1.463 | 25.653 | 23.244 | 43.759 | 0 | 0 | 0 | -0 | 0 | -40.569 |
| Operating Income
| -6.928 | -14.818 | -31.316 | -55.608 | -75.513 | -22.48 | 8.94 | 76.58 | -15.242 | 23.639 | 64.741 |
| Operating Income Ratio
| 0.088 | 1.359 | 12.808 | 1.911 | 2.947 | 1.381 | 0.212 | 1.614 | -0.964 | 2.831 | 2.263 |
| Total Other Income Expenses Net
| -0.314 | 0.536 | -0.14 | -1.422 | -2.431 | 0.39 | -0.13 | 1.339 | -0.092 | -0.286 | -0.196 |
| Income Before Tax
| -7.242 | -14.282 | -31.456 | -57.03 | -0 | -0 | 0 | 0 | -0 | 0 | 64.545 |
| Income Before Tax Ratio
| 0.092 | 1.31 | 12.865 | 1.96 | 0 | 0 | 0 | 0 | -0 | 0 | 2.257 |
| Income Tax Expense
| -7.242 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 |
| Net Income
| -7.242 | -14.282 | -31.456 | -57.03 | 21.881 | 21.881 | 21.881 | 21.881 | 21.881 | 21.881 | 64.545 |
| Net Income Ratio
| 0.092 | 1.31 | 12.865 | 1.96 | -0.854 | -1.344 | 0.519 | 0.461 | 1.384 | 2.621 | 2.257 |
| EPS
| -0.42 | -0.66 | -1.44 | -2.61 | 1 | 21,881,465 | 21,881,465 | 21,881,465 | 21,881,465 | 21,881,465 | 2.95 |
| EPS Diluted
| -0.42 | -0.66 | -1.44 | -2.61 | 1 | 390,000 | -130,000 | 1,339,000 | -92,000 | -286,000 | 2.95 |
| EBITDA
| -6.928 | -14.818 | -31.316 | -55.608 | -73.082 | -22.87 | 9.07 | 75.241 | -15.15 | 23.925 | 64.741 |
| EBITDA Ratio
| 0.088 | 1.359 | 12.808 | 1.911 | 2.852 | 0.037 | 0.731 | 2.075 | 0.42 | 5.452 | 2.263 |